FDA recall Z-1021-2023

Biokit, S.A. · Class II · device

Product

biokitHSV-2 Rapid Test, REF: 300028001

Reason for recall

HSV-2 rapid test may report false positive results.

Distribution

US Nationwide distribution in the states of NY, CA, IN, NC, VA.

Key facts

Status
Ongoing
Initiation date
2022-09-28
Report date
2023-02-01
Voluntary/Mandated
Voluntary: Firm initiated
Location
Llica D'Amunt, N/A, Spain

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1021-2023